Core Laboratories Inc. /DE/ (CLB) Form 10-Q — Apr 30, 2026
Core Laboratories reported a net loss of $0.8 million for the first quarter of 2026, compared to net income of $0.1 million in the prior year period, as revenue declined 1% to $121.8 million. The decrease in revenue was primarily driven by lower activity levels in international markets and operational disruptions caused by ongoing geopolitical conflicts in the Middle East and Russia/Ukraine, along with severe weather in North America and Europe. The company completed a refinancing transaction, repaying $45.0 million of its 4.09% 2021 Senior Notes Series A at maturity using a $50.0 million delayed draw term loan under its credit facility at a variable rate.
Key figures
- Revenue Yoy
- -1%
Price after filing
Close on the filing date to close N calendar days later (from $14.65). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.